Mouse Models of Alzheimer's Disease. (Q51095457)

29 March 2018

title

Mouse Models of Alzheimer's Disease. (English)

1 reference

29 March 2018

author

Sandra Villegas

4

1 reference

29 March 2018

author name string

Gisela Esquerda-Canals

1

1 reference

29 March 2018

Laia Montoliu-Gaya

2

1 reference

29 March 2018

Jofre Güell-Bosch

3

1 reference

29 March 2018

publication date

10 March 2017

1 reference

29 March 2018

Journal of Alzheimer's Disease

published in

1 reference

29 March 2018

volume

57

1 reference

29 March 2018

page(s)

1171-1183

1 reference

29 March 2018

issue

4

1 reference

29 March 2018

Intracellular amyloid-beta in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Reassessing the amyloid cascade hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Animal models of dementia and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Recent rodent models for Alzheimer's disease: clinical implications and basic research

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Modeling Alzheimer's disease in transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

A reliable way to detect endogenous murine β-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Transgenesis by means of blastocyst-derived embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Gene therapy using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Size matters: use of YACs, BACs and PACs in transgenic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Reconstitution of gamma-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E: from lipid transport to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Identification and expression cloning of a leptin receptor, OB-R

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

New animal models of Alzheimer's disease that display insulin desensitization in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

The physiology of obese-hyperglycemic mice [ob/ob mice].

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Alzheimer mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Genetic mouse models of brain ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170045

21 January 2018

Identifiers

DOI

10.3233/JAD-170045

1 reference

29 March 2018

release_jv3j4bdky5c5fjr4tgs4ywaq54

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jv3j4bdky5c5fjr4tgs4ywaq54

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

28304309

1 reference

29 March 2018